News

All news

2019-06-19

ACCORD LAUNCH ANIDULAFUNGIN 100 MG POWDER FOR CONCENTRATE FOR SOLUTION FOR INFUSION

Accord Healthcare is delighted to announce the launch of Anidulafungin 100 mg powder for concentrate for solution for infusion.

This medicine is indicated for the treatment of invasive candidiasis in adult patients.

Please check the Summary of Product Characteristic (SPC) for full indications. The SPC is available here

All news